PMC:7736111 / 48-387 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"3","span":{"begin":23,"end":28},"obj":"Disease"},{"id":"19","span":{"begin":101,"end":111},"obj":"Species"},{"id":"20","span":{"begin":154,"end":162},"obj":"Species"},{"id":"21","span":{"begin":188,"end":196},"obj":"Species"},{"id":"27","span":{"begin":88,"end":97},"obj":"Disease"},{"id":"28","span":{"begin":145,"end":153},"obj":"Disease"}],"attributes":[{"id":"A3","pred":"tao:has_database_id","subj":"3","obj":"MESH:D003643"},{"id":"A19","pred":"tao:has_database_id","subj":"19","obj":"Tax:2697049"},{"id":"A20","pred":"tao:has_database_id","subj":"20","obj":"Tax:9606"},{"id":"A21","pred":"tao:has_database_id","subj":"21","obj":"Tax:9606"},{"id":"A27","pred":"tao:has_database_id","subj":"27","obj":"MESH:D007239"},{"id":"A28","pred":"tao:has_database_id","subj":"28","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"inants for Recovery or Death\n\nAbstract\nHyperactivation of the host immune system during infection by SARS-CoV-2 is the leading cause of death in COVID-19 patients. It is also evident that patients who develop mild/moderate symptoms and successfully recover display functional and well-regulated immune response. Whereas a delayed initial i"}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T3","span":{"begin":30,"end":38},"obj":"Sentence"},{"id":"T4","span":{"begin":39,"end":163},"obj":"Sentence"},{"id":"T5","span":{"begin":164,"end":311},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"inants for Recovery or Death\n\nAbstract\nHyperactivation of the host immune system during infection by SARS-CoV-2 is the leading cause of death in COVID-19 patients. It is also evident that patients who develop mild/moderate symptoms and successfully recover display functional and well-regulated immune response. Whereas a delayed initial i"}